Guselkumab effectiveness in real-world settings: observations from an Italian multicentre study
{{output}}
Objectives: Guselkumab is a biologic disease-modifying antirheumatic drug (bDMARD) with proven efficacy for psoriatic arthritis (PsA) in randomized controlled trials. Evidence of its effectiveness from clinical practice remains l... ...
